SlideShare a Scribd company logo
Current Strategy in
Management of
Severe Sepsis
KW HO
February 2013 issues of Critical Care
Medicine and Intensive Care Medicine.
Outline
Definitions
Investigations
Fluids
Antibiotics
Vasopressors
Steroids
Glucose
 Bone RC, et al. Chest 1992; 101: 1644-55
 Sepsis = presence (probable or documented) of
infection together with systemic manifestation of
infection
 Severe sepsis = sepsis + organ
dysfuction/tissue hypoperfusion
 Sepsis-induced hypotension = SBP<90
mmHg OR MAP<70 mmHg
 Septic Shock = sepsis-induced hypotension
persisting despite adequate fluid resuscitation
 Sepsis-induced tissue hypoperfusion =
infection-induced hypotension, elevated lactate,
or oliguria
Diagnostic Criteria of Sepsis
Severe Sepsis
 Sepsis-induced hypotension
 Lactate > upper limits laboratory normal
 Urine output < 0.5 mL/kg/hr for more than 2 hrs
despite adequate fluid resuscitation
 Acute lung injury with Pao2/Fio2 < 250 in the
absence of pneumonia as infection source
 Acute lung injury with Pao2/Fio2 < 200 in the
presence of pneumonia as infection source
 Creatinine > 2.0 mg/dL (176.8 μmol/L)
 Bilirubin > 2 mg/dL (34.2 μmol/L)
 Platelet count < 100,000 μL
 Coagulopathy (INR> 1.5)
Significance of Definitions
Mortality Rates
 3% No SIRS Criteria
 7% with 2 SIRS Criteria
 10% with 3 SIRS Criteria
 17% with 4 SIRS Cirteria
 18% with Sepsis
 29% with Severe Sepsis
 40% with Septic Shock
Blood C+S
 30–50 % of patients presenting with severe
sepsis or shock have positive blood cultures
 10 mls per bottle
 In patients with indwelling catheters (for more
than 48 hrs), at least one blood culture should
be drawn through each lumen of each
vascular access device (if feasible, especially
for vascular devices with signs of
inflammation, catheter dysfunction, or
indicators of thrombus formation). Obtaining
blood cultures peripherally and through a
vascular access device is an important
strategy. If the same organism is recovered
from both cultures, the likelihood that the
organism is causing the severe sepsis is
enhanced
CRP vs Procalcitonin
Advantage of Procalcitonin
 -it rises more quickly at the onset of inflammation
and
 -cleared more quickly as inflammation resolves
 -correlate more closely with the severity of sepsis
<0.05 ng/ml=normal
<0.05-0.5 ng/ml=low risk or local infection
0.5-2 ng/ml=mod risk of severe sepsis
2-10 ng/ml=high risk of severe sepsis
>10 ng/ml = septic shock
CRP vs Procalcitonin
 The utility of procalcitonin levels or CRP to
discriminate sepsis from other causes of generalized
inflammation (eg, postoperative, other forms of
shock) has not been demonstrated.
 No recommendation can be given for the use of
these markers to distinguish between severe
infection and other acute inflammatory states
 Giamarellos-Bourboulis EJ et al. J Crit Care 2004; 19:152–157
 Uzzan B et al. Crit Care Med 2006; 34:1996–2003
 Tang BM et al. Lancet Infect Dis 2007; 7:210–217
Q1)
What fluids and what BP targets are you
aiming for ?
A) NS- aim for SBP > 120
B) NS- aim for DBP > 80
C) NS- aim for MAP > 65
D) Gelafundin- aim for MAP > 65
E) Albumin man… sure problems settle
Q2)
What CVP targets are you aiming for ?
A) CVP 5-10 cmH20
B) CVP 8-12 cm H20
C) CVP 10-15 cm H20
D) CVP 8-12 mmHg
E) ???? mmHg or cm H20 ..
Initial Resuscitation(First 6 Hours)
 Begin resuscitation immediately in
patients with hypotension or elevated
serum lactate 4 mmol/L
 Resuscitation goals
–CVP 8–12 mm Hg
–Mean arterial pressure > 65 mm Hg
–Urine output 0.5 mL/kg/hr
–Central venous (superior vena cava)
oxygen saturation 70% or mixed venous
65%
–Targets to lower lactate
Mortality Rate
 both hypotension and lactate ≥ 4 mmol/L
(46.1%)
 Hypotension alone (36.7%)
 Lactate ≥ 4 mmol/L alone (30%)
Fluid Therapy
Crystalloid
30ml/kg
More rapid or greater amounts may be
needed
Fluid challenge technique
Assess BP, HR, pulse pressure
What about Colloid??
 A meta-analysis of 56 randomized trials found no
overall difference in mortality between
crystalloids and artificial colloids (modified
gelatins, HES, dextran) when used for initial fluid
resuscitation
Perel P et al.Cochrane Database Syst Rev 2011; 3:CD000567
 Hydroxyethyl starches (HES) are NOT
recommended
---No difference in mortality
---Increased risks of RRT
What about Albumin???
 Add albumin to initial fluid resuscitation
with crystalloid when pts need a
substantial amount of crystalloid
Antibiotics
 Empirical antibiotics
Should be broad spectrum to cover the
likely pathogens
To be administered within first hour
 Antibiotics should be reassessed daily and
de-escalate to prevent resistance
 Typical duration 7-10 days
 Combinations of antibiotics may be needed for
pts with difficult-to-treat or multi-drug
resistant pathogens
Vassopressors & Inotropic Therapy
 Target MAP > 65mmHg
 First choice: Noradrenaline
 Adrenaline can be added when additional
agent is required
 Vasopressin can be added to
noradrenaline
---0.03 unit/min
 Dopamine
as an alternative to noradrenaline only in
pts with low risks of tachyarrythmias and
bradycardias
Not be used for renal protection
 Dobutamine
Especially in the presence of myocardial
dysfunction as suggested by elevated
cardiac filling pressures and low cardiac
output
Noradrenaline Dopamine
Increases vasoconstriction Increases stroke volume and
heart rate
Little change in heart rate Causes more tachycardia and
more arrhythmogenic
More potent – more useful in
reversing hypotension
Less potent
Steroid….To give or not to give??
 IV hydrocortisone be given to adult septic
shock patients if blood pressure is
inadequate with appropriate fluid
resuscitation and vasopressor therapy
 IV hydrocortisone not be given to adult
septic shock patients if blood pressure is
adequate with appropriate fluid
resuscitation and vasopressor therapy
 Corticosteroid therapy
o IV hydrocortisone 200mg/day in
continuous infusion
 Corticosteroids should not be administered
in the absence of shock
 Only when fluids and vasopressors are
inadequate to restore haemodynamic
instability
Blood Sugar Control
 Commencing insulin dosing when two
consecutive blood glucose levels are > 10
mmol/L.
 This approach should target an upper blood
glucose level ≤ 10mmol/L rather than an
upper target blood glucose ≤ 6.2 mmol/L
(1A).
 Blood glucose values be monitored every 1 to
2 hrs until glucose values and insulin infusion
rates are stable, then every 4 hrs thereafter
(1C).
THANK YOU

More Related Content

Similar to Current Strategy in Management of Severe Sepsis.pptx

Sepsis dr samra
Sepsis dr samraSepsis dr samra
Sepsis dr samra
SamraAhmad2
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
dlecolst
 
Bundle of sepsis
Bundle of sepsisBundle of sepsis
Bundle of sepsis
Zainal Maarif
 
20201118 sepsis and septic shock
20201118 sepsis and septic shock20201118 sepsis and septic shock
20201118 sepsis and septic shock
GBKwak
 
Mss
MssMss
Mss
storeup
 
Sepsis Treatment
Sepsis TreatmentSepsis Treatment
Sepsis Treatment
MedicineAndHealth
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020
EmanElrefaie
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
Babak Jebelli
 
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptxSEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
mainhamza411
 
Perforation - Interactive case on Septic Shock
Perforation - Interactive case on Septic ShockPerforation - Interactive case on Septic Shock
Perforation - Interactive case on Septic Shock
Vitrag Shah
 
Sepsis
SepsisSepsis
Sepsis
jstyle4u
 
Severe Sepsis & Septic Shock
Severe Sepsis & Septic ShockSevere Sepsis & Septic Shock
Severe Sepsis & Septic Shock
Andrew Ferguson
 
Septicemia international management guideline
Septicemia international management guidelineSepticemia international management guideline
Septicemia international management guideline
NeurologyKota
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
ratna savitrie
 
Blood component therapy part I
Blood component therapy part IBlood component therapy part I
Blood component therapy part I
anaesthesiology-mgmcri
 
Blood component therapy
Blood component therapyBlood component therapy
Blood component therapy
anaesthesiology-mgmcri
 
Pericardial diseases 2020 final
Pericardial diseases 2020 finalPericardial diseases 2020 final
Pericardial diseases 2020 final
jamiel
 
hemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptx
hemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptxhemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptx
hemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptx
Dr Shabeer D
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
Sun Yai-Cheng
 
02 shock
02 shock02 shock

Similar to Current Strategy in Management of Severe Sepsis.pptx (20)

Sepsis dr samra
Sepsis dr samraSepsis dr samra
Sepsis dr samra
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
 
Bundle of sepsis
Bundle of sepsisBundle of sepsis
Bundle of sepsis
 
20201118 sepsis and septic shock
20201118 sepsis and septic shock20201118 sepsis and septic shock
20201118 sepsis and septic shock
 
Mss
MssMss
Mss
 
Sepsis Treatment
Sepsis TreatmentSepsis Treatment
Sepsis Treatment
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptxSEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
SEPSIS AND SEPTIC SHOCK PRESENTATION.pptx
 
Perforation - Interactive case on Septic Shock
Perforation - Interactive case on Septic ShockPerforation - Interactive case on Septic Shock
Perforation - Interactive case on Septic Shock
 
Sepsis
SepsisSepsis
Sepsis
 
Severe Sepsis & Septic Shock
Severe Sepsis & Septic ShockSevere Sepsis & Septic Shock
Severe Sepsis & Septic Shock
 
Septicemia international management guideline
Septicemia international management guidelineSepticemia international management guideline
Septicemia international management guideline
 
Sepsis and septic shock
Sepsis and septic shockSepsis and septic shock
Sepsis and septic shock
 
Blood component therapy part I
Blood component therapy part IBlood component therapy part I
Blood component therapy part I
 
Blood component therapy
Blood component therapyBlood component therapy
Blood component therapy
 
Pericardial diseases 2020 final
Pericardial diseases 2020 finalPericardial diseases 2020 final
Pericardial diseases 2020 final
 
hemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptx
hemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptxhemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptx
hemodynamicstabilisationinsepticshock-090814084800-phpapp01.pptx
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
 
02 shock
02 shock02 shock
02 shock
 

Recently uploaded

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 

Recently uploaded (20)

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 

Current Strategy in Management of Severe Sepsis.pptx

  • 1. Current Strategy in Management of Severe Sepsis KW HO
  • 2. February 2013 issues of Critical Care Medicine and Intensive Care Medicine.
  • 4.  Bone RC, et al. Chest 1992; 101: 1644-55
  • 5.  Sepsis = presence (probable or documented) of infection together with systemic manifestation of infection  Severe sepsis = sepsis + organ dysfuction/tissue hypoperfusion  Sepsis-induced hypotension = SBP<90 mmHg OR MAP<70 mmHg  Septic Shock = sepsis-induced hypotension persisting despite adequate fluid resuscitation  Sepsis-induced tissue hypoperfusion = infection-induced hypotension, elevated lactate, or oliguria
  • 7.
  • 8.
  • 9. Severe Sepsis  Sepsis-induced hypotension  Lactate > upper limits laboratory normal  Urine output < 0.5 mL/kg/hr for more than 2 hrs despite adequate fluid resuscitation  Acute lung injury with Pao2/Fio2 < 250 in the absence of pneumonia as infection source  Acute lung injury with Pao2/Fio2 < 200 in the presence of pneumonia as infection source  Creatinine > 2.0 mg/dL (176.8 μmol/L)  Bilirubin > 2 mg/dL (34.2 μmol/L)  Platelet count < 100,000 μL  Coagulopathy (INR> 1.5)
  • 10. Significance of Definitions Mortality Rates  3% No SIRS Criteria  7% with 2 SIRS Criteria  10% with 3 SIRS Criteria  17% with 4 SIRS Cirteria  18% with Sepsis  29% with Severe Sepsis  40% with Septic Shock
  • 11.
  • 12.
  • 13. Blood C+S  30–50 % of patients presenting with severe sepsis or shock have positive blood cultures  10 mls per bottle  In patients with indwelling catheters (for more than 48 hrs), at least one blood culture should be drawn through each lumen of each vascular access device (if feasible, especially for vascular devices with signs of inflammation, catheter dysfunction, or indicators of thrombus formation). Obtaining blood cultures peripherally and through a vascular access device is an important strategy. If the same organism is recovered from both cultures, the likelihood that the organism is causing the severe sepsis is enhanced
  • 14. CRP vs Procalcitonin Advantage of Procalcitonin  -it rises more quickly at the onset of inflammation and  -cleared more quickly as inflammation resolves  -correlate more closely with the severity of sepsis <0.05 ng/ml=normal <0.05-0.5 ng/ml=low risk or local infection 0.5-2 ng/ml=mod risk of severe sepsis 2-10 ng/ml=high risk of severe sepsis >10 ng/ml = septic shock
  • 15.
  • 16.
  • 17.
  • 18. CRP vs Procalcitonin  The utility of procalcitonin levels or CRP to discriminate sepsis from other causes of generalized inflammation (eg, postoperative, other forms of shock) has not been demonstrated.  No recommendation can be given for the use of these markers to distinguish between severe infection and other acute inflammatory states  Giamarellos-Bourboulis EJ et al. J Crit Care 2004; 19:152–157  Uzzan B et al. Crit Care Med 2006; 34:1996–2003  Tang BM et al. Lancet Infect Dis 2007; 7:210–217
  • 19. Q1) What fluids and what BP targets are you aiming for ? A) NS- aim for SBP > 120 B) NS- aim for DBP > 80 C) NS- aim for MAP > 65 D) Gelafundin- aim for MAP > 65 E) Albumin man… sure problems settle
  • 20. Q2) What CVP targets are you aiming for ? A) CVP 5-10 cmH20 B) CVP 8-12 cm H20 C) CVP 10-15 cm H20 D) CVP 8-12 mmHg E) ???? mmHg or cm H20 ..
  • 21.
  • 22. Initial Resuscitation(First 6 Hours)  Begin resuscitation immediately in patients with hypotension or elevated serum lactate 4 mmol/L  Resuscitation goals –CVP 8–12 mm Hg –Mean arterial pressure > 65 mm Hg –Urine output 0.5 mL/kg/hr –Central venous (superior vena cava) oxygen saturation 70% or mixed venous 65% –Targets to lower lactate
  • 23. Mortality Rate  both hypotension and lactate ≥ 4 mmol/L (46.1%)  Hypotension alone (36.7%)  Lactate ≥ 4 mmol/L alone (30%)
  • 24. Fluid Therapy Crystalloid 30ml/kg More rapid or greater amounts may be needed Fluid challenge technique Assess BP, HR, pulse pressure
  • 25. What about Colloid??  A meta-analysis of 56 randomized trials found no overall difference in mortality between crystalloids and artificial colloids (modified gelatins, HES, dextran) when used for initial fluid resuscitation Perel P et al.Cochrane Database Syst Rev 2011; 3:CD000567  Hydroxyethyl starches (HES) are NOT recommended ---No difference in mortality ---Increased risks of RRT
  • 26. What about Albumin???  Add albumin to initial fluid resuscitation with crystalloid when pts need a substantial amount of crystalloid
  • 27. Antibiotics  Empirical antibiotics Should be broad spectrum to cover the likely pathogens To be administered within first hour  Antibiotics should be reassessed daily and de-escalate to prevent resistance  Typical duration 7-10 days  Combinations of antibiotics may be needed for pts with difficult-to-treat or multi-drug resistant pathogens
  • 28.
  • 29. Vassopressors & Inotropic Therapy  Target MAP > 65mmHg  First choice: Noradrenaline  Adrenaline can be added when additional agent is required  Vasopressin can be added to noradrenaline ---0.03 unit/min
  • 30.  Dopamine as an alternative to noradrenaline only in pts with low risks of tachyarrythmias and bradycardias Not be used for renal protection  Dobutamine Especially in the presence of myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output
  • 31. Noradrenaline Dopamine Increases vasoconstriction Increases stroke volume and heart rate Little change in heart rate Causes more tachycardia and more arrhythmogenic More potent – more useful in reversing hypotension Less potent
  • 32. Steroid….To give or not to give??  IV hydrocortisone be given to adult septic shock patients if blood pressure is inadequate with appropriate fluid resuscitation and vasopressor therapy  IV hydrocortisone not be given to adult septic shock patients if blood pressure is adequate with appropriate fluid resuscitation and vasopressor therapy
  • 33.  Corticosteroid therapy o IV hydrocortisone 200mg/day in continuous infusion  Corticosteroids should not be administered in the absence of shock  Only when fluids and vasopressors are inadequate to restore haemodynamic instability
  • 34. Blood Sugar Control  Commencing insulin dosing when two consecutive blood glucose levels are > 10 mmol/L.  This approach should target an upper blood glucose level ≤ 10mmol/L rather than an upper target blood glucose ≤ 6.2 mmol/L (1A).  Blood glucose values be monitored every 1 to 2 hrs until glucose values and insulin infusion rates are stable, then every 4 hrs thereafter (1C).